Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and gemcitabine in advanced soft tissue sarcoma
NCT03524898Phase 2Terminated
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Oct 2018
- Primary completion
- Feb 2022
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in soft tissue sarcoma (STS), sponsored by Swiss Group for Clinical Cancer Research. Started Oct 2018; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03524898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03524898.